See our Melanotan-2 Bloodwork Guide for monitoring recommendations
JAMA 302 (11): 1202-9, 2009
Working concentrations for cell-based assays typically sit in the nanomolar to low-micromolar range, which means the stock will need substantial serial dilution in your assay buffer
It is the most widely recognized therapeutic peptide in the compounding world, used primarily for: Accelerating gut healing (leaky gut, IBD, NSAID-induced damage) Repairing tendons, ligaments, muscles, and bones Reducing systemic inflammation Neuroprotective effects Promoting angiogenesis (new blood vessel formation) For a full breakdown, see our comprehensive BPC-157 guide
The long-term implications of sustained, high-intensity c-Met activation are not fully characterized
Most patients notice reduced appetite within 3-5 days of their first injection, though peak results develop over 8-16 weeks as the body adapts to steady dosing